Persistent URL of this record https://hdl.handle.net/1887/94591
In Collections
This item can be found in the following collections:
![The mortality benefit seen with the newer more potent oral P2Y(12) inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
The mortality benefit seen with the newer more potent oral P2Y(12) inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis
- All authors
- Jukema, J.W.; Alber, H.; Widimsky, P.
- Date
- 2018-04-30
- Journal
- Cor et Vasa
- Volume
- 60
- Issue
- 2
- Pages
- E127 - E132